Work

Characteristics of participants in a fully decentralized dermatologic clinical trial evaluating the safety and efficacy of topical ruxolitinib monotherapy for atopic dermatitis (Preprint)

Year: 2025
Type: preprint
Abstract: UNSTRUCTURED A decentralized dermatological clinical trial model can be used to improve participation for populations underrepresented in clinical research.
Institution: Yale University
Language: English
Field: Medicine
Open Access status: gold
Funder: Incyte
OpenAlex ID: W4414191829
Cites: 7
Cited by:
Related to: